PATENT CLAIM ANALYSIS

Application Number: 15918645
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Reprogramming factor, in particular, by targeting natural antisense polynucleotides of a Reprogramming factor. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Reprogramming factors.

Claim (Index 10):
The oligonucleotide of  claim 1 , wherein the oligonucleotide is of at least about 5 to 30 nucleotides in length and hybridizes to an antisense and/or sense strand of a Reprogramming factor polynucleotide wherein said oligonucleotide has at least about 90% sequence identity to a complementary sequence of at least about ten consecutive nucleic acids of the antisense and/or sense coding and/or noncoding nucleic acid sequences of the Reprogramming factor polynucleotide.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.59459
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13320637', '14588442', '14534323', '14814895', '14297101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8311817624064646
- 35 USC 102 Novelty (BERT): 0.5736683946939822
- Combined Prediction Score: 0.8054304256352164
- Mean Citation Score: 468.007694
- Max Citation Score: 491.61438
- Similarity Product: 385.1764460733032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test